{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:20:22Z","timestamp":1791829222514,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ajog.2008.01.002","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T03:01:02Z","timestamp":1209870062000},"page":"167.e1-167.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility"],"prefix":"10.1016","volume":"199","author":[{"given":"Audrey T.","family":"Moynihan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Hehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan M.","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Nicholas","family":"Europe-Finner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9344","key":"10.1016\/j.ajog.2008.01.002_bib1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(02)11476-0","article-title":"Preterm delivery","volume":"360","author":"Slattery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2008.01.002_bib2","first-page":"1","article-title":"Births: final data for 2004","volume":"55","author":"Martin","year":"2006","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2008.01.002_bib3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-25-6-792","article-title":"Human chorionic gonadotrophin pattern and its relation to the sex of the fetus","volume":"25","author":"Brody","year":"1965","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.ajog.2008.01.002_bib4","first-page":"704","article-title":"Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility","volume":"108","author":"Slattery","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2008.01.002_bib5","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1210\/jc.2003-030221","article-title":"Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel","volume":"88","author":"Doheny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.01.002_bib6","first-page":"917","article-title":"Human myometrial chorionic gonadotrophin\/lutenizing hormone receptors in preterm and term deliveries","volume":"79","author":"Zuo","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.01.002_bib7","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1210\/jc.2004-1962","article-title":"Regulation of expression of the chorionic gonadotrophin\/lutenizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (SP1), SP3, SP4, SP-Like proteins and histone deacetylases","volume":"90","author":"Phillips","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ajog.2008.01.002_bib8","first-page":"50","article-title":"Transcriptional regulation of the protein kinase A regulatory subunit II\u03b1 (RII\u03b1 PKA) in the myometrium","volume":"13","author":"Karolczak","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ajog.2008.01.002_bib9","first-page":"1835","article-title":"Down regulation of G\u03b1s in human myometrium in term and pretern labour: a mechanism for parturition","volume":"79","author":"Europe-Finner","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.01.002_bib10","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2002-021862","article-title":"Human myometrial quiescence and activation during gestation and parturition involve dramatic changes in expression and activity of particulate type II (RII\u03b1) protein kinase A holoenzyme","volume":"88","author":"MacDougall","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.01.002_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"10.1016\/j.ajog.2008.01.002_bib12","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.ajog.2008.01.002_bib13","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1210\/jc.2005-0574","article-title":"Functional coupling of {beta} 3-adremoreceptors and large conductance calcium-activated potassium channels in human uterine myocytes","volume":"90","author":"Doheny","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ajog.2008.01.002_bib14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ajog.2006.01.106","article-title":"Inhibitory effect of leptin on human uterine contractility in vitro","volume":"195","author":"Moynihan","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ajog.2008.01.002_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bies.950170510","article-title":"Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function","volume":"17","author":"Yoshida","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/j.ajog.2008.01.002_bib16","first-page":"549","article-title":"Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis","volume":"103","author":"Wetzel","year":"2005","journal-title":"J Neuruosurg"},{"issue":"5","key":"10.1016\/j.ajog.2008.01.002_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1442-2042.2006.01344.x","article-title":"Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 G1 cell cycle arrest","volume":"13","author":"Li","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajog.2008.01.002_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yexmp.2006.02.004","article-title":"Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukaemic U937 cells","volume":"82","author":"Woo","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.ajog.2008.01.002_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ajog.2008.01.002_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2008-1043809","article-title":"Valproic acid for the treatment of pediatric malignant glioma","volume":"211","author":"Driever","year":"1999","journal-title":"Klin Padiatr"},{"issue":"3","key":"10.1016\/j.ajog.2008.01.002_bib21","first-page":"357","article-title":"Valproic acid, but not its non-teratogenic analogu 2-isopropylpentanoic acid affects proliferation, viability and neuronal differentiation of the human teratocarcinoma cell line Ntera-2","volume":"19","author":"Skladchikova","year":"1998","journal-title":"Neurotox"},{"issue":"4","key":"10.1016\/j.ajog.2008.01.002_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1535-7163.425.3.4","article-title":"The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondira-dependent apoptosis of melanoma cells","volume":"3","author":"Zhang","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajog.2008.01.002_bib23","first-page":"1","article-title":"Signal transduction pathways as therapeuric targets","volume":"1091","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2008.01.002_bib24","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubuquitination","volume":"13","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ajog.2008.01.002_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2741\/2079","article-title":"Acetylation in the regulation of metalloproteinase and tissue inhibitor of metalloproteinases gene expression","volume":"12","author":"Clark","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajog.2008.01.002_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4161\/cc.2.5.466","article-title":"A link between histone deacetylase inhibitors and NF-kappaB signaling","volume":"2","author":"Trepel","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ajog.2008.01.002_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9440(10)63320-2","article-title":"Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues","volume":"165","author":"Waltregny","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2008.01.002_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility","volume":"19","author":"Waltregny","year":"2005","journal-title":"FASEB J"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:28:01Z","timestamp":1757586481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937808000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0002937808000173"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2008.01.002","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2008.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}